Introduction
Glucocorticoid-induced apoptosis in lymphocytes consists of the signaling phase, the commitment step marked by the release of cytochrome c from the mitochondria, and the execution phase in which caspases degrade cellular proteins (1) . The execution phase has been well-characterized and is common to many agents that induce apoptosis (1) . The signaling phase of glucocorticoid-induced apoptosis is not completely understood. Identifying the critical signals is key to determining sources of resistance in the clinic since glucocorticoids are a primary drug in the treatment of lymphoid malignancies.
The commitment to undergo apoptosis following glucocorticoid treatment is determined by a complex interaction of pro-apoptotic and survival signals (reviewed in refs. [2] [3] [4] . Transcriptional events, including the upregulation of Bim (5), and metabolic events, such as an increase in Ca 2+ flux (6) and increased neutral sphingomyelinase activity (7) , are required. Recently, we showed that an increase in hydrogen peroxide (H 2 O 2 ) is also a required signaling event (8) . Glucocorticoid treatment of WEHI7.2 murine thymic lymphoma cells causes an increase in H 2 O 2 during apoptosis signaling. Cells that overexpress catalase also produce increased H 2 O 2 following glucocorticoid treatment; however, if the quantity of catalase is sufficient to remove the H 2 O 2 , the cells do not undergo apoptosis.
In our previous studies, we established the necessity of an H 2 O 2 signal, but we did not determine the source of the increased H 2 O 2 . Previous work by Tonomura et al shows that glucocorticoid treatment of immature thymocytes causes an increase in reactive oxygen species (ROS) from Complex III of the electron transport chain (ETC) (9) . The study by Tonomura et al did not determine whether there are additional ROS sources or whether tumor cells have the same glucocorticoid response. These details are significant as tumor cells often metabolize ROS differently than non-transformed cells (10) . The goal of the current study was to use the WEHI7.2 model to identify the source of the H 2 O 2 produced during the signaling phase of glucocorticoid-induced apoptosis in lymphoma cells.
Materials and methods
Reagents. 15-Lipoxygenase inhibitor, baicalein, piriprost and 8,11,14-eicosatriynoic acid were purchased from Cayman Chemical Co. (Madison, WI, USA). JC-1 and DAPI were purchased from Invitrogen/Molecular Probes (Carlsbad, CA, USA). All other drugs and chemicals were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA) unless otherwise noted.
Cell culture. The WEHI7.2 mouse thymic lymphoma cell line (11) was maintained in suspension cultures in DMEM (Invitrogen) with 10% calf serum (Hyclone Laboratories, Ogden, UT, USA) in a humidified 37˚C environment with 5% CO 2 (12 (16) . All of the inhibitors and vehicles were first titrated for toxicity in the presence and absence of dexamethasone. The inhibitors were used at concentrations that showed no toxicity. All drug treatments were continuous.
Protein and enzyme/ETC complex activity measurements. Cellular protein was measured in clarified lysates using the BCA Protein Assay kit (ThermoScientific, Rockford, IL, USA) according to the manufacturer's instructions. Superoxide dismutase (SOD) activity was measured as previously described (17) . Clarified whole cell lysates were used for measurements of Complex I (18) and Complex III (19) activities. Complex IV activity was measured by first isolating mitochondria using the ThermoScientific Mitochondrial Isolation kit for Cultured Cells (ThermoScientific) and then measuring the activity using the method of Zhang et al (20) . Values were normalized to cellular or mitochondrial protein as appropriate and expressed as the percentage of the vehicletreated control.
Amplex
® Red measurements. The rate of H 2 O 2 efflux was determined by measuring the rate of oxidation of the fluorogenic indicator Amplex ® Red (Invitrogen) in the presence of horseradish peroxidase. Briefly, cells were resuspended in phenol red-free DMEM (Invitrogen) with 10% calf serum (Hyclone Laboratories) containing 50 µM Amplex ® Red and 0.1 unit/ml horseradish peroxidase. The rate of increase in fluorescence (Ex 510/Em 590) was measured using a Synergy HT plate reader (Bio Tek Instruments, Winooski, VT, USA). Rates were normalized to cellular protein measured as described above.
MitoSOX measurements. Cells were incubated in a final concentration of 5 µM MitoSOX (Molecular Probes/Invitrogen) in DMEM with 10% calf serum at 37˚C for 3 h. The rate of increase in MitoSOX fluorescence (Ex 530/Em 590) was measured using a Synergy HT plate reader (BioTek Instruments, Inc.). Rates were normalized to the sample protein measured as described above. Localization of the MitoSOX signal was determined by treating cells with MitoSOX, 0.1 µM JC-1 and 0.1 µM DAPI for 30 min. Fluorescent images were captured using the DeltaVision Restoration Microscopy System (Applied Precision, Inc., Issaquah, WA, USA) at the following wavelengths; MitoSOX (Ex 530/Em 590), JC-1 (Ex 360/ Em 568), DAPI (Ex 358/Em 461). Data were collected and processed using Scion Image (Scion, Frederick, MD, USA).
roGFP2 measurements. The redox sensitive GFP plasmid, p-EGFP-N1/roGFP2 with a mitochondrial targeting sequence (21) (a donation from Dr S. James Remmington), was electroporated into WEHI7.2 and variant cells using the Amaxa Nucleofactor™ II (Amaxa GmbH, Germany). Following transfection, cells were incubated in phenol red-free DMEM (Invitrogen) supplemented with 10% calf serum for 24 h, then treated with 1 µM dexamethasone or vehicle control for 12 h. Cells were imaged using the DeltaVision Restoration Microscopy System using excitation lines at 407 nm and 488 nm and a 510/21 nm emission filter. Data were collected and processed using Scion Image. Images were corrected for background fluorescence by subtracting the intensity of a nearby cell-free region. Fluorescence excitation ratios were then calculated by dividing the integrated intensities of the cells at the different excitation wavelengths using the formulas described in Hanson et al (21) . Between 20 and 35 cells were analyzed per treatment. Mitochondrial localization of the roGFP2 was measured as described for the MitoSOX.
Statistics. Means were compared using t-tests or ANOVA, where appropriate, using the algorithms in Excel (Microsoft, Redmond, WA, USA). P≤0.05 was considered to indicate a statistically significant result.
Results
Superoxide is a major source of the H 2 O 2 signal. H 2 O 2 can be produced directly or as a byproduct of superoxide dismutation. Therefore, one possible source of the H 2 O 2 signal in response to glucocorticoids is increased superoxide that is metabolized into H 2 O 2 . To determine whether the H 2 O 2 signal originates from superoxide, we measured the H 2 O 2 signal due to dexamethasone, a synthetic glucocorticoid, in the presence of Tiron (4,5-dihydroxy-m-benzenedisulfonic acid), which scavenges superoxide (22) . For these measurements, we chose a 12 h dexamethasone treatment as we have previously determined that this time point is in the signaling phase of dexamethasone-induced apoptosis in WEHI7.2 cells (8) . As shown in Fig. 1 , Tiron caused a dose-dependent decrease in H 2 O 2 efflux in response to a 12 h dexamethasone treatment. Cytosolic enzymatic sources do not increase H 2 O 2 production in response to dexamethasone. A number of cytosolic or membrane bound enzymes produce superoxide or H 2 O 2 either as a product of their enzymatic activities or from leakage due to the one electron reduction of oxygen. These include xanthine oxidase, NAD(P)H oxidase, cyclooxygenase, lipoxygenase and cytochrome P450. To determine whether these enzymes contribute to the increased H 2 O 2 produced in response to dexamethasone treatment we measured the H 2 O 2 efflux due to dexamethasone treatment in the presence of inhibitors of these enzymes. The use of the inhibitors was expected to decrease the H 2 O 2 efflux if the target enzyme was producing increased superoxide/H 2 O 2 in response to dexamethasone. As shown in Fig. 2 (23, 24) . We tested whether dexamethasone treatment increased mitochondrial matrix oxidants by measuring the fluorescence of MitoSOX, a mitochondrial matrix-targeted probe that fluoresces after reacting with ROS. Twelve hours after the addition of dexamethasone, the mitochondrial matrix ROS was higher than that in the control cells (Fig. 3A) . As shown in Fig. 3B , 95.97±0.45% (n=14) of the fluorescent MitoSOX signal co-localized with JC-1, a mitochondrion-specific dye.
We then used a mitochondrially targeted roGFP2 probe to measure the mitochondrial redox environment in response to dexamethasone. This probe measures the relative oxidation of the mitochondrial glutathione pool (21) . Quantitation of the oxidized roGFP2 signal indicated that the mitochondrial glutathione pool became oxidized in response to dexamethasone (Fig. 3C ). As shown in Fig. 3D , 97.21±0.24% (n=16) of the mitochondrially targeted roGFP2 co-localized with JC-1.
Glucocorticoids inhibit ETC complex activity.
When oxidative phosphorylation is inhibited, the ROS produced from the ETC increases (23, 24) . To determine whether glucocorticoids inhibited oxidative phosphorylation, we measured the effect of glucocorticoid treatment on the activity of Complexes I, III and IV. As shown in Fig. 4 , glucocorticoid treatment inhibited Complex I and Complex III activity, but had no effect on Complex IV activity.
Mn superoxide dismutase (MnSOD) activity increases in response to glucocorticoid treatment.
We previously demonstrated that an increase in H 2 O 2 is a required signal for glucocorticoid-induced apoptosis in lymphoma cells (8) .
The data from the current study indicate that the majority of the H 2 O 2 generated by dexamethasone treatment originates from superoxide. To participate in apoptosis signaling the superoxide must be metabolized to H 2 O 2 . SODs metabolize superoxide to H 2 O 2 . Therefore, we measured the activities of MnSOD, which is located in the mitochondrial matrix, and Cu,Zn superoxide dismutase (Cu,ZnSOD) which is located in the intermembrane space and cytosol. As shown in Fig. 5 , MnSOD activity increased in response to dexamethasone treatment but there was no change in Cu,ZnSOD activity in response to dexamethasone. These data indicate that SOD is available to metabolize superoxide.
Discussion
Our data indicate that mitochondria are the primary source of the H 2 O 2 signal during glucocorticoid-induced apoptosis in lymphoma cells. We did not find an additional source of H 2 O 2 among the enzymes we tested. The current study characterizes the ROS signal in lymphoma cells and fits a model whereby glucocorticoids inhibit Complexes I and III of the ETC causing an increase in mitochondrial superoxide production. The superoxide is metabolized to H 2 O 2 by SOD and/or other enzymes. The resulting H 2 O 2 is a necessary signal for glucocorticoid-induced apoptosis (8) . The production of H 2 O 2 is concomitant with the oxidation of the mitochondrial glutathione pool. Oxidation of mitochondrial glutathione can contribute to apoptotic signaling (25) .
The ability of dexamethasone to disrupt mitochondrial metabolism likely contributes to the increase in H 2 O 2 observed following glucocorticoid treatment. We previously showed that dexamethasone treatment inhibits glucose uptake (26) . In (27) . In other cell types when glutamate is used as a substrate, mitochondrial ROS generation increases under conditions where Complex I and, in particular, Complex III are inhibited (24) . The combination of a switch to glutamate metabolism and the inhibition of Complex III caused by dexamethasone treatment is likely to contribute to the increase in mitochondrial ROS generation. Our data suggest that the main species of oxidant generated by dexamethasone treatment is superoxide. This is consistent with the ability of dexamethasone to inhibit Complexes I and III. Inhibition of Complexes I and III is expected to produce superoxide via the reverse flow of electrons and from the Q cycle in Complex III (23 (29) . Activated BAX plays a role in mitochondrial membrane pore formation for the release of cytochrome c (30) . An increase in H 2 O 2 also stimulates the peroxidase activity of cytochrome c. This results in oxidation of cardiolipin and release of cytochrome c from the outer surface of the inner mitochondrial membrane (31) . Unteathering cytochrome c from the membrane is required to allow cytochrome c to move into the cytosol through the pores in the outer mitochondrial membrane (30, 31) . Our data suggest an additional downstream target, the oxidation of the mitochondrial glutathione pool. In other cells types, oxidation of the mitochondrial glutathione pool is an apoptotic signal (25) .
Our data indicate that mitochondria are central to apoptotic signaling during glucocorticoid-induced apoptosis. In addition to the release of apoptotic proteins, mitochondria are the source of the H 2 O 2 signal required for this process. Our previous data indicate that the removal of the H 2 O 2 signal serves as a protective mechanism (8) . The current study suggests that an inability of the mitochondria to generate a H 2 O 2 signal in response to glucocorticoids could contribute to the glucocorticoid resistance observed in the clinic. A B
